Serina Therapeutics News

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WILSON KAREN J

Jan 15 16:28 ET

Serina Therapeutics | 3: Initial statement of beneficial ownership of securities-Director WILSON KAREN J

Jan 15 16:18 ET

Serina Therapeutics | 8-K: Current report

Jan 15 11:51 ET

Serina Therapeutics | 8-K: Current report

Jan 6 16:10 ET

Serina Therapeutics | 8-K: Current report

Dec 26, 2024 11:54 ET

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory

Dec 19, 2024 16:09 ET

Serina Therapeutics | 8-K: Current report

Dec 18, 2024 16:19 ET

Serina Therapeutics | 8-K: Current report

Dec 11, 2024 07:16 ET

Serina Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Juvenescence Limited(42.0%),JuvVentures (UK) Limited(41.3%)

Dec 9, 2024 16:52 ET

Serina Therapeutics | 8-K: Current report

Dec 2, 2024 17:20 ET

Serina Therapeutics | 424B3: Prospectus

Nov 22, 2024 16:22 ET

Serina Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Broadwood Partners, L.P.(2.1%),Broadwood Capital, Inc.(2.1%), etc.

Nov 14, 2024 17:13 ET

Serina Therapeutics | 8-K: Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Nov 12, 2024 17:11 ET

Serina Therapeutics | 10-Q: Quarterly report

Nov 12, 2024 16:11 ET

Serina Therapeutics | ARS: Annual Report to Security Holders

Nov 6, 2024 16:48 ET

Serina Therapeutics | DEFA14A: Others

Nov 6, 2024 16:39 ET

Serina Therapeutics | DEF 14A: Definitive information statements

Nov 6, 2024 06:37 ET

Serina Therapeutics | DEFC14A: Others

Oct 31, 2024 09:17 ET

Serina Therapeutics | 8-K: Current report

Oct 2, 2024 08:34 ET

Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory

Sep 24, 2024 16:32 ET